These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 39279630)

  • 1. A case of VEXAS with microcytic anemia: don't be mislead by an associated condition!
    Squalli K; Wolff L; Vandergheynst F
    Acta Clin Belg; 2024 Sep; ():1-3. PubMed ID: 39279630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. VEXAS syndrome.
    Nakajima H; Kunimoto H
    Int J Hematol; 2024 May; ():. PubMed ID: 38819628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristic bone marrow findings in patients with UBA1 somatic mutations and VEXAS syndrome.
    Patel N; Dulau-Florea A; Calvo KR
    Semin Hematol; 2021 Oct; 58(4):204-211. PubMed ID: 34802541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The VEXAS Syndrome: Uncontrolled Inflammation and Macrocytic Anaemia in a 77-Year-Old Male Patient.
    Himmelmann A; Brücker R
    Eur J Case Rep Intern Med; 2021; 8(4):002484. PubMed ID: 33987129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS.
    Ferrada MA; Sikora KA; Luo Y; Wells KV; Patel B; Groarke EM; Ospina Cardona D; Rominger E; Hoffmann P; Le MT; Deng Z; Quinn KA; Rose E; Tsai WL; Wigerblad G; Goodspeed W; Jones A; Wilson L; Schnappauf O; Laird RS; Kim J; Allen C; Sirajuddin A; Chen M; Gadina M; Calvo KR; Kaplan MJ; Colbert RA; Aksentijevich I; Young NS; Savic S; Kastner DL; Ombrello AK; Beck DB; Grayson PC
    Arthritis Rheumatol; 2021 Oct; 73(10):1886-1895. PubMed ID: 33779074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How I diagnose and manage VEXAS syndrome.
    Hagiya A; Siddiqi IN; Wang E; Lu CM
    Am J Clin Pathol; 2024 Jul; 162(1):28-40. PubMed ID: 38511841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive morphologic characterization of bone marrow biopsy findings in a large cohort of patients with VEXAS syndrome: A single-institution longitudinal study of 111 bone marrow samples from 52 patients.
    Olteanu H; Patnaik M; Koster MJ; Herrick JL; Chen D; He R; Viswanatha D; Warrington KJ; Go RS; Mangaonkar AA; Kourelis T; Hines A; Gibson SE; Peterson JF; Reichard KK
    Am J Clin Pathol; 2024 Jun; 161(6):609-624. PubMed ID: 38413044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1.
    Obiorah IE; Patel BA; Groarke EM; Wang W; Trick M; Ombrello AK; Ferrada MA; Wu Z; Gutierrez-Rodrigues F; Lotter J; Wilson L; Hoffmann P; Cardona DO; Patel N; Dulau-Florea A; Kastner DL; Grayson PC; Beck DB; Young NS; Calvo KR
    Blood Adv; 2021 Aug; 5(16):3203-3215. PubMed ID: 34427584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population.
    Beck DB; Bodian DL; Shah V; Mirshahi UL; Kim J; Ding Y; Magaziner SJ; Strande NT; Cantor A; Haley JS; Cook A; Hill W; Schwartz AL; Grayson PC; Ferrada MA; Kastner DL; Carey DJ; Stewart DR
    JAMA; 2023 Jan; 329(4):318-324. PubMed ID: 36692560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and genetic features of Japanese cases of MDS associated with VEXAS syndrome.
    Kunimoto H; Miura A; Maeda A; Tsuchida N; Uchiyama Y; Kunishita Y; Nakajima Y; Takase-Minegishi K; Yoshimi R; Miyazaki T; Hagihara M; Yamazaki E; Kirino Y; Matsumoto N; Nakajima H
    Int J Hematol; 2023 Oct; 118(4):494-502. PubMed ID: 37062784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful azacitidine therapy for myelodysplastic syndrome associated with VEXAS syndrome.
    Kataoka A; Mizumoto C; Kanda J; Iwasaki M; Sakurada M; Oka T; Fujimoto M; Yamamoto Y; Yamashita K; Nannya Y; Ogawa S; Takaori-Kondo A
    Int J Hematol; 2023 Jun; 117(6):919-924. PubMed ID: 36641501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of VEXAS syndrome presenting with unusual bone marrow granulomas: a diagnostic dilemma.
    Vu KT; Wolfe RM; Lambird JE; Maracaja DLV
    BMC Rheumatol; 2023 Jul; 7(1):18. PubMed ID: 37430338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Coexistence of Multiple Myeloma and Auricular Chondritis in VEXAS Syndrome.
    Matsumoto H; Fujita Y; Fukatsu M; Ikezoe T; Yokose K; Asano T; Tsuchida N; Maeda A; Yoshida S; Hashimoto H; Temmoku J; Matsuoka N; Yashiro-Furuya M; Sato S; Murakami M; Sato H; Sakuma C; Kawashima K; Shakespear N; Uchiyama Y; Watanabe H; Kirino Y; Matsumoto N; Migita K
    Front Immunol; 2022; 13():897722. PubMed ID: 35757758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEXAS Syndrome in a Patient with Myeloproliferative Neoplasia.
    Austestad J; Madland TM; Sandnes M; Haslerud TM; Benneche A; Reikvam H
    Case Rep Hematol; 2023; 2023():6551544. PubMed ID: 36879894
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm.
    Li P; Venkatachalam S; Ospina Cordona D; Wilson L; Kovacsovics T; Moser KA; Miles RR; Beck DB; George T; Tantravahi SK
    Blood Adv; 2022 Jan; 6(2):405-409. PubMed ID: 34649277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Further characterization of clinical and laboratory features in VEXAS syndrome: large-scale analysis of a multicentre case series of 116 French patients.
    Georgin-Lavialle S; Terrier B; Guedon AF; Heiblig M; Comont T; Lazaro E; Lacombe V; Terriou L; Ardois S; Bouaziz JD; Mathian A; Le Guenno G; Aouba A; Outh R; Meyer A; Roux-Sauvat M; Ebbo M; Zhao LP; Bigot A; Jamilloux Y; Guillotin V; Flamarion E; Henneton P; Vial G; Jachiet V; Rossignol J; Vinzio S; Weitten T; Vinit J; Deligny C; Humbert S; Samson M; Magy-Bertrand N; Moulinet T; Bourguiba R; Hanslik T; Bachmeyer C; Sebert M; Kostine M; Bienvenu B; Biscay P; Liozon E; Sailler L; Chasset F; Audemard-Verger A; Duroyon E; Sarrabay G; Borlot F; Dieval C; Cluzeau T; Marianetti P; Lobbes H; Boursier G; Gerfaud-Valentin M; Jeannel J; Servettaz A; Audia S; Larue M; Henriot B; Faucher B; Graveleau J; de Sainte Marie B; Galland J; Bouillet L; Arnaud C; Ades L; Carrat F; Hirsch P; Fenaux P; Fain O; Sujobert P; Kosmider O; Mekinian A; ;
    Br J Dermatol; 2022 Mar; 186(3):564-574. PubMed ID: 34632574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chronic anemia and unexplained inflammation: think of VEXAS syndrome].
    van Daele PLA; van der Made CI; Leavis HL; Hak AEL; Potjewijd J; Rutgers AB
    Ned Tijdschr Geneeskd; 2023 Apr; 167():. PubMed ID: 37078566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradigm shift in monogenic autoinflammatory diseases and systemic vasculitis: The VEXAS syndrome.
    Hernández-Rodríguez J; Mensa-Vilaró A; Aróstegui JI
    Med Clin (Barc); 2022 Nov; 159(10):489-496. PubMed ID: 36049972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEXAS syndrome unveiled: a multidimensional journey from clinical presentation to management.
    Escobar Gil T; Horton DD; Borja Montes OF; Babu D; Sheikh AB
    Proc (Bayl Univ Med Cent); 2024; 37(5):858-861. PubMed ID: 39165813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEXAS syndrome: An update.
    Khitri MY; Hadjadj J; Mekinian A; Jachiet V
    Joint Bone Spine; 2024 Jul; 91(4):105700. PubMed ID: 38307404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.